Treatment of Patients with High Grade Non-Hodgkin's Lymphomas and Central Nervous System Involvement: Is Radiation an Essential Component of Therapy?

References

• Magrath I. T., Janus C., Edwards B. K., Spiegel R., Jaffe E. S., Berard C. W., Miliauskas J., Morris K., Barnwell R. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984; 63: 1102–1111
   PubMed Web of Science ®Google Scholar
• Sariban E., Edwards B., Janus C., Magrath I. Central nervous system involvement in American Burkitt's lymphoma. J. Clin. Oncol 1983; 1: 677–681
   PubMed Web of Science ®Google Scholar
• Philip T., Pinkerton R., Biron P., Ladjadj Y., Bouffet E., Souillet G., Philippe N., Frappaz D., Freycon F., Chauvin F., Brunat-Mentigny M. Effective multiagent chemotherapy in children with advanced B-cell lymphoma: who remains the high risk patient?. Brit. J. Haematol 1987; 65: 159–164
   PubMed Web of Science ®Google Scholar
• Haddy T. B., Adde M. A., Magrath I. T. CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign?. J. Clin. Oncol 1991; 9: 1973–1982
   PubMed Web of Science ®Google Scholar
• Hoppe R. T. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer 1985; 55: 2176–2183
   PubMed Web of Science ®Google Scholar
• Hoerni-Simon G., Suchaud J. P., Eghbali H., Coindre J. M., Hoerni B. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma: a study of 30 cases in a series of 498 patients. Oncology 1987; 44: 98–101
   PubMed Web of Science ®Google Scholar
• Ziegler J. L., Magrath I. T., Olweny C. L. M. Cure of Burkitt's lymphoma: ten-year follow-up of 157 Ugandan patients. Lancet 1979; 2: 936–938
   PubMed Web of Science ®Google Scholar
• Magrath I. T. African Burkitt's lymphoma: history, biology, clinical features, and treatment. Am. J. Pediatr. Hematol. Oncol 1991; 13: 222–246
   PubMedGoogle Scholar
• Ziegler J. L., DeVita V. T., Graw R. G., Herzig G., Leventhal B. G., Levine A. S., Pomeroy T. C. Combined modality treatment of American Burkitt' s lymphoma. Cancer 1976; 38: 2225–2231
   PubMed Web of Science ®Google Scholar
• Ziegler J. L., Magrath I. T., Deisseroth A. B., Glaubiger D. L., Kent H. C., Pizzo P. A., Poplack D. G., Levine A. S. Combined modality treatment of Burkitt's lymphoma. Cancer Treat. Rep 1978; 62: 2031–2034
   PubMedGoogle Scholar
• Weintraub M., Adde M., Shad A., Horak I., Seibel N., Neely J., Magrath I. Profound peripheral neuropathy associated with the administration of colony stimulating factors. Blood 1994; 84, (Suppl I)
   Web of Science ®Google Scholar
• Magrath I. T., Adde M., Sandlund J., Jain V. Ifosfamide in the treatment of high-grade recurrent non-Hodgkin's lymphomas. Hematological Oncology 1991; 9: 267–274
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Paryani S. B., Donaldson S. S., Amylon M. D., Link M. P. Cranial nerve involvement in children with leukemia and lymphoma. J. Clin. Oncol 1983; 1: 542–545
   PubMed Web of Science ®Google Scholar
• Ingram L. C., Fairclough D. L., Furman W. L., Sandlund J. T., Kun L. E., Rivera G. K., Pui C.-H. Cranial nerve palsy in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Cancer 1991; 67: 2262–2268
   PubMed Web of Science ®Google Scholar
• Patte C., Leverger G., Perel Y., Rubie H., Otten J., Nelken B., Gentet J. C., De Lumley L., Berendt H., Brugieres L. for the SFOP. Updated results of the LMB 86 protocol of the French Pediatric Oncology Society (SFOP) for B-cell non-Hodgkin's lymphomas (B-NHL) with CNS involvement (CNS+) and B-ALL. Med. Pediatr. Oncol 1990; 19: 397, (Abstract 122).
   Google Scholar
• Bowman W. P., Shuster J., Cook B., Behm F., Pullen J., Berard C., Murphy S. Improved survival for children with B cell (SIg+) acute lymphoblastic leukemia (B-ALL) and stage IV small non-cleaved cell lymphoma (SNCCL). Proc. Ann. Meet. Am. Soc. Clin. Oncol 1992; 11: 277, (Abstract 919).
   Google Scholar
• Reiter A., Schrappe M., Ludwig W-D., Lampert F., Harbott J., Henze G., Niemeyer C. M., Gadner H., Muller-Weihrich S., Ritter J., Odenwald E., Riehm H. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 1992; 80: 2471–2478
   PubMed Web of Science ®Google Scholar
• Moss H. A., Nannis E. D., Poplack D. G. The effects of prophylactic treatment of the central nervous system on the intellectual functioning of children with acute lymphocytic leukemia. Am. J. Med 1981; 71: 47–52
   PubMed Web of Science ®Google Scholar
• Browers P., Riccardi R., Fedio P., Poplack D. G. Long-term neuropsychologic sequelae of childhood leukemia: correlation with CT brain scan abnormalities. J. Pediatr 1985; 106: 723–728
   PubMed Web of Science ®Google Scholar
• Bleyer W. A., Poplack D. G. Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries. Semin. Oncol 1985; 12: 131–148
   PubMed Web of Science ®Google Scholar
• Browers P., Poplack D. Memory and learning scquelae in long-term survivors of acute lymphoblastic leukemia: association with attention deficits. Am. J. Pediatr. Hematol. Oncol 1990; 12: 174–181
   PubMedGoogle Scholar
• Mulhern R. K., Fairclough D., Ochs J. A prospective comparison of neuropsycholog performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J. Clin. Oncol 1991; 9: 1348–1356
   PubMed Web of Science ®Google Scholar
• Pinkel D., Woo S. Prevention and treatment of meningeal leukemia in children. Blood 1994; 84: 355–366
   PubMed Web of Science ®Google Scholar
• Shalet S. M., Clayton P. E., Price D. A. Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. Horm. Res 1988; 30: 53–61
   PubMed Web of Science ®Google Scholar
• Schriock E. A., Schell M. J., Carter M., Hustu O., Ochs J. J. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J. Clin. Oncol 1991; 9: 400–405
   PubMed Web of Science ®Google Scholar
• Maxon H. R. Radiation-induced thyroid disease. Med. Clin. N. Amer 1985; 69: 1049–1061
   PubMed Web of Science ®Google Scholar
• Barnes N. D. Effects of external irradiation on the thyroid gland in childhood. Horm. Res 1988; 30: 84–89
   PubMed Web of Science ®Google Scholar
• Hancock S. L., Cox R. S., McDougall I. R. Thyroid diseases after treatment of Hodgkin's disease. New Engl. J. Med 1991; 325: 599–605
   PubMed Web of Science ®Google Scholar
• Rimm I. J., Li F. C., Tarbell N. J., Winston K. R., Sallan S. E. Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia: a 13-year experience from the Dana-Farber Cancer Institute and the Children's Hospital. Cancer 1987; 59: 1506–1508
   PubMed Web of Science ®Google Scholar
• Neglia J. P., Meadows A. T., Robison L. L., Kim T. H., Newton W. A., Ruymann F. B., Sather H. N., Hammond G. D. Second neoplasms after acute lymphoblastic leukemia in childhood. New Engl. J. Med 1991; 325: 1330–1336
   PubMed Web of Science ®Google Scholar
• van Leeuwen F. E., Klokman W. J., Hagenbeek A., Noyon R., van den Belt-Dusebout A. W., van Kerkhoff E. H. M., van Heerde P., Somers R. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J. Clin. Oncol 1994; 12: 312–325
   PubMed Web of Science ®Google Scholar